Vori Health
Series B in 2025
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.
Thyme Care
Series C in 2024
Thyme Care is a healthcare company focused on providing comprehensive oncology care management services. It partners with health plans to deliver an integrated oncology solution that emphasizes whole-person care for cancer patients. By employing a tech-enabled platform, Thyme Care offers personalized support through physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. This model generates actionable insights that help healthcare providers identify at-risk patients earlier, facilitating timely access to quality resources and care. Thyme Care aims to enhance the cancer experience through early and ongoing intervention, ensuring that every cancer patient receives the individualized care they need.
Heartbeat Health
Series C in 2024
Heartbeat Health, Inc. is a healthcare technology company based in New York that specializes in providing virtual cardiovascular disease prevention and management services. Founded in 2017, it offers a data-driven platform that enables real-time consultations between patients and cardiologists. Through its web-based services, Heartbeat Health facilitates secure communication, allowing patients to receive medical advice, treatment, and dietary consultations from healthcare professionals. The company's focus is on reducing cardiovascular risk and improving patient outcomes by promoting continuous engagement and monitoring of heart health. By leveraging technology, Heartbeat Health aims to enhance the quality of care for patients and support at-risk organizations in managing cardiovascular conditions more effectively.
Thyme Care
Venture Round in 2024
Thyme Care is a healthcare company focused on providing comprehensive oncology care management services. It partners with health plans to deliver an integrated oncology solution that emphasizes whole-person care for cancer patients. By employing a tech-enabled platform, Thyme Care offers personalized support through physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. This model generates actionable insights that help healthcare providers identify at-risk patients earlier, facilitating timely access to quality resources and care. Thyme Care aims to enhance the cancer experience through early and ongoing intervention, ensuring that every cancer patient receives the individualized care they need.
Eleanor Health
Venture Round in 2024
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Established in 2019 and headquartered in Waltham, Massachusetts, Eleanor Health offers comprehensive, whole-person care for mental health and substance misuse. Its services include evidence-based outpatient care, medication-assisted treatment for addiction, and personalized recovery plans, which are delivered through a network of outpatient clinics, virtually, and in community and home settings. This integrated approach aims to expedite the recovery process for individuals suffering from substance use disorders.
Sempre Health
Venture Round in 2023
Sempre Health, Inc. operates a behavior-based healthcare pricing platform that collaborates with health plans and pharmaceutical manufacturers to offer dynamic co-payment adjustments based on individual patient adherence and behavior. Founded in 2015 and based in San Francisco, the company analyzes prescription records to forecast the most appropriate price for medications based on a patient's timely adherence. Patients receive personalized SMS messages that inform them of potential discounts and encourage prompt prescription refills, such as alerts indicating that filling a prescription today may cost $10, while delaying could raise the price to $30. This innovative approach not only aims to improve patients' access to affordable care but also generates valuable real-world data on patient price sensitivities and cost behaviors.
Octave is a clinical platform developer focused on transforming the care landscape for multiple sclerosis and other neurodegenerative diseases. The company's platform generates, analyzes, and integrates data to provide a comprehensive approach aimed at reducing the overall cost of care. By optimizing healthcare medications and utilization, Octave enables pharmaceutical companies to enhance the entire lifecycle of drug discovery, clinical trials, and post-marketing processes through the use of real-world evidence. This innovative approach seeks to improve patient outcomes while streamlining healthcare practices.
Strive Health
Series C in 2023
Strive Health, LLC, founded in 2018 and based in Denver, Colorado, specializes in solutions for chronic kidney disease. The company operates dialysis centers and employs a technology-enhanced clinical model to improve patient outcomes and experiences. Strive Health works collaboratively with innovative payers and providers to transform kidney care by focusing on the entire healthcare journey of chronic kidney disease patients, from primary care engagement to dialysis treatment. The company utilizes predictive analytics and comparative data to identify at-risk patients and aims to reinvent primary care to address kidney disease proactively, reducing the need for inpatient services and promoting home dialysis options. Backed by notable investors, Strive Health is committed to enhancing the management and care of patients with chronic kidney disease.
Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.
Medix Infusion
Series B in 2023
Medix Infusion, Inc. is a healthcare provider based in Arlington, Texas, specializing in ambulatory and home infusion therapy services for patients with chronic and acute illnesses. Established in 2020, the company offers a range of pharmacy services, including the placement of PICC lines, and the administration of anti-infectives, anti-virals, IV antibiotics, anti-fungals, biologics, specialty injectables, total parenteral nutrition (TPN), and hydration therapy. Medix Infusion is committed to enhancing patient care by delivering personalized infusion therapies both at home and in clinical settings. The company focuses on serving patients in rural and underserved areas, ensuring access to essential physician-prescribed medical treatments. Its technology-enabled platform aims to improve the overall healthcare experience for those requiring specialized infusion therapies.
DispatchHealth
Venture Round in 2022
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.
Upfront Healthcare Services
Series C in 2022
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.
Abacus Insights
Series C in 2022
Abacus Insights, Inc. is a company that develops a cloud-based data integration and interoperability platform tailored for the healthcare sector. Founded in 2017 and headquartered in New York City, Abacus Insights organizes and exchanges healthcare data from various sources and formats, both structured and unstructured. The platform provides a secure unified data infrastructure designed to enhance analytics capabilities, enabling healthcare providers to improve costs and patient outcomes. By offering intelligent data management solutions, the company helps healthcare organizations generate actionable insights, improve the consumer experience, and enhance care quality while lowering costs. In addition to its main office in New York, Abacus Insights also has a presence in Boston, Massachusetts, where it provides maintenance and support services to its clients.
Waltz Health
Series A in 2022
Waltz Health is focused on enhancing the pharmaceutical supply chain by collaborating with consumers, payers, and pharmacies to develop innovative, technology-driven solutions for pricing, distribution, and prescription of medications. The company creates AI-driven marketplaces that aim to reduce costs and provide valuable insights for users, facilitating informed decision-making in prescription care. By offering consumer tools designed to empower individuals and help payers manage their pharmacy benefits, Waltz Health strives to improve accessibility and affordability in the healthcare sector.
Embold Health
Series B in 2022
Embold Health, Inc. is a healthcare analytics company based in Nashville, Tennessee, that specializes in analyzing de-identified medical data to evaluate the quality and cost of care provided by doctors and hospitals. Founded in 2017, the company offers a platform that enables employers, health plans, and consumers to identify top-performing healthcare providers who deliver appropriate care. By utilizing insights from its analytics, Embold Health aims to improve healthcare outcomes and facilitate informed decision-making for patients and their families. Additionally, their online search platform allows users to access medical research and clinical guidelines, further supporting the selection of quality care options.
Wildflower Health
Venture Round in 2022
Wildflower Health, Inc. is a health engagement platform based in San Francisco, California, that provides smartphone-based health programs aimed at connecting healthcare payers with families across the United States. Founded in 2012, the company offers a maternity program called Due Date Plus, which addresses engagement challenges by assisting women in early pregnancy and facilitating connections with care managers. Additionally, Wildflower Health provides GROW, a family health program that focuses on mothers and encompasses pediatric and family health. Its platform delivers personalized health milestones based on age and gender, along with resources such as on-device messaging, appointment reminders, health risk assessments, and provider referrals. By utilizing user-centered design and technology, Wildflower Health aims to empower families to make informed healthcare decisions and support their individual health needs over time.
Scipher Medicine
Series D in 2022
Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.
mPulse Mobile
Venture Round in 2022
mPulse Mobile, Inc. is a healthcare technology company based in Encino, California, specializing in communication solutions designed to enhance consumer health and wellness. The company offers mPulse, a cloud-based intelligent mobile messaging platform that features pre-configured workflows to address various healthcare challenges, including missed appointments, medication adherence, and disease management. Their solutions encompass a wide range of areas such as medication adherence, preventive care and screenings, chronic condition management, and optimization of health plan experiences. By leveraging conversational AI and analytics, mPulse Mobile aims to empower healthcare organizations to engage effectively with their customers, encouraging the adoption of healthier behaviors. Founded in 2014, the company serves diverse sectors, including Medicare, Medicaid, commercial plans, health systems, and wellness initiatives.
Genome Medical
Series C in 2021
Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.
Vori Health
Series A in 2021
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.
Main Street Health
Funding Round in 2021
Main Street Health is a provider of value-based, care-focused healthcare services aimed at addressing rural wellness concerns. The company's healthcare services are data-driven, and it provides partner clinics with employees, technology, critical access hospitals, community health centers, and possibilities to flourish in the care delivery model, allowing rural residents to receive the high-quality treatment they need.
Eleanor Health
Series B in 2021
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Established in 2019 and headquartered in Waltham, Massachusetts, Eleanor Health offers comprehensive, whole-person care for mental health and substance misuse. Its services include evidence-based outpatient care, medication-assisted treatment for addiction, and personalized recovery plans, which are delivered through a network of outpatient clinics, virtually, and in community and home settings. This integrated approach aims to expedite the recovery process for individuals suffering from substance use disorders.
Heartbeat Health
Series B in 2021
Heartbeat Health, Inc. is a healthcare technology company based in New York that specializes in providing virtual cardiovascular disease prevention and management services. Founded in 2017, it offers a data-driven platform that enables real-time consultations between patients and cardiologists. Through its web-based services, Heartbeat Health facilitates secure communication, allowing patients to receive medical advice, treatment, and dietary consultations from healthcare professionals. The company's focus is on reducing cardiovascular risk and improving patient outcomes by promoting continuous engagement and monitoring of heart health. By leveraging technology, Heartbeat Health aims to enhance the quality of care for patients and support at-risk organizations in managing cardiovascular conditions more effectively.
Ideon develops a healthcare data platform for the employee benefits sector. Its suite of application programming interfaces provides the infrastructure, or middleware, to help insurance and digital health companies access flows of data, creating modern digital experiences throughout the employee benefits ecosystem.
Cityblock
Series C in 2021
Cityblock Health is a technology-driven provider focused on meeting the complex health and social needs of Medicaid and Medicare populations. The company delivers a personalized health system that integrates primary care, behavioral health, and social services, partnering with community-based organizations to ensure tailored support for each member. By investing in prevention-oriented care and utilizing technology to enhance coordination and communication, Cityblock aims to improve health outcomes while reducing costs. During the COVID-19 pandemic, the organization developed a model to identify members at high risk, demonstrating its commitment to addressing urgent health challenges within communities.
Scipher Medicine
Series C in 2021
Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.
Strive Health
Series B in 2021
Strive Health, LLC, founded in 2018 and based in Denver, Colorado, specializes in solutions for chronic kidney disease. The company operates dialysis centers and employs a technology-enhanced clinical model to improve patient outcomes and experiences. Strive Health works collaboratively with innovative payers and providers to transform kidney care by focusing on the entire healthcare journey of chronic kidney disease patients, from primary care engagement to dialysis treatment. The company utilizes predictive analytics and comparative data to identify at-risk patients and aims to reinvent primary care to address kidney disease proactively, reducing the need for inpatient services and promoting home dialysis options. Backed by notable investors, Strive Health is committed to enhancing the management and care of patients with chronic kidney disease.
DispatchHealth
Series D in 2021
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.
Octave is a clinical platform developer focused on transforming the care landscape for multiple sclerosis and other neurodegenerative diseases. The company's platform generates, analyzes, and integrates data to provide a comprehensive approach aimed at reducing the overall cost of care. By optimizing healthcare medications and utilization, Octave enables pharmaceutical companies to enhance the entire lifecycle of drug discovery, clinical trials, and post-marketing processes through the use of real-world evidence. This innovative approach seeks to improve patient outcomes while streamlining healthcare practices.
Upfront Healthcare Services
Series B in 2020
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.
mPulse Mobile
Series C in 2020
mPulse Mobile, Inc. is a healthcare technology company based in Encino, California, specializing in communication solutions designed to enhance consumer health and wellness. The company offers mPulse, a cloud-based intelligent mobile messaging platform that features pre-configured workflows to address various healthcare challenges, including missed appointments, medication adherence, and disease management. Their solutions encompass a wide range of areas such as medication adherence, preventive care and screenings, chronic condition management, and optimization of health plan experiences. By leveraging conversational AI and analytics, mPulse Mobile aims to empower healthcare organizations to engage effectively with their customers, encouraging the adoption of healthier behaviors. Founded in 2014, the company serves diverse sectors, including Medicare, Medicaid, commercial plans, health systems, and wellness initiatives.
Cityblock
Series B in 2020
Cityblock Health is a technology-driven provider focused on meeting the complex health and social needs of Medicaid and Medicare populations. The company delivers a personalized health system that integrates primary care, behavioral health, and social services, partnering with community-based organizations to ensure tailored support for each member. By investing in prevention-oriented care and utilizing technology to enhance coordination and communication, Cityblock aims to improve health outcomes while reducing costs. During the COVID-19 pandemic, the organization developed a model to identify members at high risk, demonstrating its commitment to addressing urgent health challenges within communities.
DispatchHealth
Series C in 2020
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.
Abacus Insights
Series B in 2020
Abacus Insights, Inc. is a company that develops a cloud-based data integration and interoperability platform tailored for the healthcare sector. Founded in 2017 and headquartered in New York City, Abacus Insights organizes and exchanges healthcare data from various sources and formats, both structured and unstructured. The platform provides a secure unified data infrastructure designed to enhance analytics capabilities, enabling healthcare providers to improve costs and patient outcomes. By offering intelligent data management solutions, the company helps healthcare organizations generate actionable insights, improve the consumer experience, and enhance care quality while lowering costs. In addition to its main office in New York, Abacus Insights also has a presence in Boston, Massachusetts, where it provides maintenance and support services to its clients.
Amwell is a telehealth platform based in the United States that facilitates the digital delivery of healthcare services. Founded in 2006 and headquartered in Boston, the company connects providers, insurers, patients, and innovators to enhance access to affordable, high-quality care. Amwell offers a comprehensive platform designed to address a wide range of telehealth needs, including urgent, acute, and post-acute care, as well as chronic care management and healthy living. With extensive experience in the field, Amwell supports over 240 health systems, which encompass 2,000 hospitals, and collaborates with 55 health plan partners, reaching more than 150 million individuals through over 36,000 employers. The platform provides both on-demand and scheduled consultations, enabling diverse care models that range from primary and urgent care to specialized services such as telestroke and telepsychiatry.
Aledade, Inc. is a company that supports primary care physicians in establishing and managing accountable care organizations (ACOs) across the United States. Founded in 2014 and headquartered in Bethesda, Maryland, Aledade provides a comprehensive suite of services including data analytics, guided workflows, regulatory expertise, and payer relationships. The company aims to empower independent primary care providers by offering customized solutions, operational support, and advanced technology to enhance practice efficiency and patient care. Aledade serves a diverse range of healthcare practices, including small and large practices, community health centers, and multispecialty groups. By facilitating better care delivery and reducing overall costs, Aledade helps physicians maintain their independence while improving health outcomes for their patients.
TytoCare
Venture Round in 2020
TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.
Aitia specializes in applying Causal AI and Digital Twins to advance drug discovery and development. The company utilizes multi-omic patient data and high-performance computing to uncover the underlying biological mechanisms of diseases, creating Digital Twins for conditions such as oncology, neurodegenerative disorders, and immunology. Their Gemini Digital Twins are actively employed to explore new therapies and expedite research and development in areas like multiple myeloma, prostate cancer, Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease, with additional projects in the pipeline. Aitia collaborates with seven of the top ten pharmaceutical companies, academic research institutions, medical societies, multi-omic data firms, and patient advocacy organizations, positioning itself as a leader in the innovative intersection of technology and healthcare.
Genome Medical
Series B in 2019
Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.
Abacus Insights
Series A in 2019
Abacus Insights, Inc. is a company that develops a cloud-based data integration and interoperability platform tailored for the healthcare sector. Founded in 2017 and headquartered in New York City, Abacus Insights organizes and exchanges healthcare data from various sources and formats, both structured and unstructured. The platform provides a secure unified data infrastructure designed to enhance analytics capabilities, enabling healthcare providers to improve costs and patient outcomes. By offering intelligent data management solutions, the company helps healthcare organizations generate actionable insights, improve the consumer experience, and enhance care quality while lowering costs. In addition to its main office in New York, Abacus Insights also has a presence in Boston, Massachusetts, where it provides maintenance and support services to its clients.
DispatchHealth
Series B in 2019
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.
Cityblock
Series B in 2019
Cityblock Health is a technology-driven provider focused on meeting the complex health and social needs of Medicaid and Medicare populations. The company delivers a personalized health system that integrates primary care, behavioral health, and social services, partnering with community-based organizations to ensure tailored support for each member. By investing in prevention-oriented care and utilizing technology to enhance coordination and communication, Cityblock aims to improve health outcomes while reducing costs. During the COVID-19 pandemic, the organization developed a model to identify members at high risk, demonstrating its commitment to addressing urgent health challenges within communities.
Strive Health
Seed Round in 2019
Strive Health, LLC, founded in 2018 and based in Denver, Colorado, specializes in solutions for chronic kidney disease. The company operates dialysis centers and employs a technology-enhanced clinical model to improve patient outcomes and experiences. Strive Health works collaboratively with innovative payers and providers to transform kidney care by focusing on the entire healthcare journey of chronic kidney disease patients, from primary care engagement to dialysis treatment. The company utilizes predictive analytics and comparative data to identify at-risk patients and aims to reinvent primary care to address kidney disease proactively, reducing the need for inpatient services and promoting home dialysis options. Backed by notable investors, Strive Health is committed to enhancing the management and care of patients with chronic kidney disease.
Aledade
Corporate Round in 2019
Aledade, Inc. is a company that supports primary care physicians in establishing and managing accountable care organizations (ACOs) across the United States. Founded in 2014 and headquartered in Bethesda, Maryland, Aledade provides a comprehensive suite of services including data analytics, guided workflows, regulatory expertise, and payer relationships. The company aims to empower independent primary care providers by offering customized solutions, operational support, and advanced technology to enhance practice efficiency and patient care. Aledade serves a diverse range of healthcare practices, including small and large practices, community health centers, and multispecialty groups. By facilitating better care delivery and reducing overall costs, Aledade helps physicians maintain their independence while improving health outcomes for their patients.
Octave is a clinical platform developer focused on transforming the care landscape for multiple sclerosis and other neurodegenerative diseases. The company's platform generates, analyzes, and integrates data to provide a comprehensive approach aimed at reducing the overall cost of care. By optimizing healthcare medications and utilization, Octave enables pharmaceutical companies to enhance the entire lifecycle of drug discovery, clinical trials, and post-marketing processes through the use of real-world evidence. This innovative approach seeks to improve patient outcomes while streamlining healthcare practices.
AccessOne
Venture Round in 2018
AccessOne is a healthcare fintech company established in 2002 and based in Fort Mill, South Carolina. The company specializes in providing patient-centric payment tools designed to assist consumers in managing their healthcare costs while enhancing hospital reimbursement. AccessOne offers a range of low and no-interest payment options for various patient balance types, including high-deductible plans and financial assistance, ensuring that no patient is denied credit or negatively impacted in their credit reporting. The company’s financial engagement platform focuses on automation, digitization, and effective communication, seamlessly integrating with major health information systems to streamline processes and improve performance metrics for healthcare providers. By eliminating manual entry and facilitating better revenue capture, AccessOne supports hospitals and health systems in achieving optimal financial outcomes.
mPulse Mobile
Series B in 2018
mPulse Mobile, Inc. is a healthcare technology company based in Encino, California, specializing in communication solutions designed to enhance consumer health and wellness. The company offers mPulse, a cloud-based intelligent mobile messaging platform that features pre-configured workflows to address various healthcare challenges, including missed appointments, medication adherence, and disease management. Their solutions encompass a wide range of areas such as medication adherence, preventive care and screenings, chronic condition management, and optimization of health plan experiences. By leveraging conversational AI and analytics, mPulse Mobile aims to empower healthcare organizations to engage effectively with their customers, encouraging the adoption of healthier behaviors. Founded in 2014, the company serves diverse sectors, including Medicare, Medicaid, commercial plans, health systems, and wellness initiatives.
Livongo Health, Inc. is a consumer digital health company that specializes in providing an integrated suite of solutions for individuals managing chronic conditions, particularly diabetes. Established in 2008 and headquartered in Mountain View, California, Livongo utilizes real-time data capture and analytics to promote health behavior change through its platform, which includes cellular-connected devices, supplies, coaching, and insights driven by data science. Its product offerings encompass Livongo for diabetes, hypertension, prediabetes and weight management, and behavioral health through its myStrength platform. The company serves a diverse client base, including employers, health plans, government entities, and labor unions, primarily within the United States. Livongo aims to enhance the experience of individuals with chronic conditions by providing timely, personalized support and information, ultimately leading to improved health outcomes. In 2020, Livongo became a subsidiary of Teladoc Health, Inc.
Wildflower Health
Series C in 2018
Wildflower Health, Inc. is a health engagement platform based in San Francisco, California, that provides smartphone-based health programs aimed at connecting healthcare payers with families across the United States. Founded in 2012, the company offers a maternity program called Due Date Plus, which addresses engagement challenges by assisting women in early pregnancy and facilitating connections with care managers. Additionally, Wildflower Health provides GROW, a family health program that focuses on mothers and encompasses pediatric and family health. Its platform delivers personalized health milestones based on age and gender, along with resources such as on-device messaging, appointment reminders, health risk assessments, and provider referrals. By utilizing user-centered design and technology, Wildflower Health aims to empower families to make informed healthcare decisions and support their individual health needs over time.
Springbuk
Series B in 2018
Springbuk, Inc. operates a health analytics platform aimed at employers, brokers, and vendors. Founded in 2015 and based in Indianapolis, Indiana, the company offers cloud-based health intelligence software that integrates various data sources, including medical claims, pharmacy records, biometric information, payroll, and activity data. This unified platform allows employers to assess employee health and wellness, make informed budget and spending decisions, and identify at-risk employees. Additionally, Springbuk’s predictive modeling engine enhances employer engagement strategies by accurately forecasting healthcare costs and measuring the effectiveness of wellness programs.
Circulation
Series A in 2017
Circulation, Inc. is a Boston-based company founded in 2016 that offers a digital platform designed to enhance healthcare logistics and transportation. By leveraging the Uber driver network, Circulation facilitates non-emergency transportation for patients and clinical trial participants, ensuring they can attend medical appointments. As a preferred healthcare partner of Uber, the platform provides customizable solutions that improve the efficiency and outcomes of healthcare delivery across the United States. The service is utilized by a diverse range of users, including patients, caregivers, and healthcare providers, and is designed to comply with the Health Insurance Portability and Accountability Act (HIPAA), ensuring the privacy and security of patient information. Circulation operates as a subsidiary of LogistiCare Solutions, LLC.
Upfront Healthcare Services
Series A in 2017
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.
Phreesia is a privately held company that provides innovative software solutions aimed at enhancing patient check-in and engagement in healthcare settings. By replacing traditional patient clipboards with a wireless touchscreen device known as the PhreesiaPad, the company automates the check-in process, securely collecting personal health information in compliance with HIPAA regulations. This technology integrates seamlessly with existing electronic medical records, ensuring that physician workflows are not disrupted while capturing comprehensive patient data. Phreesia also improves the patient experience by facilitating appointment preparation, offering relevant health education, and enabling patients to verify previously recorded information. Additionally, the company focuses on activating patients in their care to optimize health outcomes through a range of services, including registration, appointment scheduling, payment processing, and post-appointment surveys. Backed by premier venture capital firms, Phreesia has raised significant funding to support its mission of enhancing the operational and financial performance of healthcare organizations.